“…Previous studies on TB subunit vaccines have provided a large number of vaccine candidate antigens for peptide-based vaccines development, such as Ag85A (Rv3804c) ( 241 ), Ag85B (Rv1886c) ( 116 , 202 , 239 , 240 ), 6-kDa early secretory antigenic target (ESAT-6, Rv3875) ( 222 , 223 , 238 , 239 ), heat shock protein HspX (also known as Hsp16.3, Acr, and 14 kDa antigen, Rv2031c) ( 115 , 146 , 202 , 210 , 211 , 242 ), TB10.4 (Rv0288) ( 2 , 115 , 211 , 240 ), Rv0476 ( 211 ), Hsp65 ( 202 ), 19-kDa lipoprotein (Rv3763) ( 202 ), Rv1733c ( 202 , 203 ), PE/PPE proteins ( 2 , 243 , 244 , 248 ), MPT64 (Rv1980c) ( 246 , 247 ), Mtb8.4 ( 2 ), and resuscitation-promoting factors (Rpfs) ( 2 , 228 ). These antigens have been reported to be attractive vaccine candidates for preventing and controlling TB.…”